Segmentation of the Prostate Transition Zone and Peripheral Zone on MR Images with Deep Learning.
Genital/Reproductive
MRI
Neural Networks
Prostate
Journal
Radiology. Imaging cancer
ISSN: 2638-616X
Titre abrégé: Radiol Imaging Cancer
Pays: United States
ID NLM: 101765309
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
18
9
2021
Statut:
ppublish
Résumé
Purpose To develop a deep learning model to delineate the transition zone (TZ) and peripheral zone (PZ) of the prostate on MR images. Materials and Methods This retrospective study was composed of patients who underwent a multiparametric prostate MRI and an MRI/transrectal US fusion biopsy between January 2013 and May 2016. A board-certified abdominal radiologist manually segmented the prostate, TZ, and PZ on the entire data set. Included accessions were split into 60% training, 20% validation, and 20% test data sets for model development. Three convolutional neural networks with a U-Net architecture were trained for automatic recognition of the prostate organ, TZ, and PZ. Model performance for segmentation was assessed using Dice scores and Pearson correlation coefficients. Results A total of 242 patients were included (242 MR images; 6292 total images). Models for prostate organ segmentation, TZ segmentation, and PZ segmentation were trained and validated. Using the test data set, for prostate organ segmentation, the mean Dice score was 0.940 (interquartile range, 0.930-0.961), and the Pearson correlation coefficient for volume was 0.981 (95% CI: 0.966, 0.989). For TZ segmentation, the mean Dice score was 0.910 (interquartile range, 0.894-0.938), and the Pearson correlation coefficient for volume was 0.992 (95% CI: 0.985, 0.995). For PZ segmentation, the mean Dice score was 0.774 (interquartile range, 0.727-0.832), and the Pearson correlation coefficient for volume was 0.927 (95% CI: 0.870, 0.957). Conclusion Deep learning with an architecture composed of three U-Nets can accurately segment the prostate, TZ, and PZ.
Identifiants
pubmed: 33929265
doi: 10.1148/rycan.2021200024
pmc: PMC8189171
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e200024Références
Acad Radiol. 2004 Feb;11(2):178-89
pubmed: 14974593
Med Phys. 2011 Nov;38(11):6093-105
pubmed: 22047374
N Engl J Med. 2009 Mar 26;360(13):1320-8
pubmed: 19297566
N Engl J Med. 2004 May 27;350(22):2239-46
pubmed: 15163773
Med Image Anal. 2014 Feb;18(2):359-73
pubmed: 24418598
Med Phys. 2019 Jul;46(7):3078-3090
pubmed: 31002381
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Thorac Dis. 2017 Oct;9(10):4125-4130
pubmed: 29268424
Radiographics. 2016 Sep-Oct;36(5):1354-72
pubmed: 27471952
Curr Opin Urol. 2014 May;24(3):256-63
pubmed: 24670870
Eur Urol. 2019 Mar;75(3):385-396
pubmed: 29908876
Cancers (Basel). 2019 Jun 14;11(6):
pubmed: 31207930
J Magn Reson Imaging. 2020 Nov;52(5):1499-1507
pubmed: 32478955
Strahlenther Onkol. 2020 Oct;196(10):932-942
pubmed: 32221622
J Med Imaging (Bellingham). 2019 Jan;6(1):014501
pubmed: 30820440
AJR Am J Roentgenol. 2021 Jan;216(1):111-116
pubmed: 32812797
J Digit Imaging. 2016 Dec;29(6):730-736
pubmed: 27363993
J Magn Reson Imaging. 2019 Apr;49(4):1149-1156
pubmed: 30350434
World J Urol. 2007 Mar;25(1):3-9
pubmed: 17364211
J Med Imaging (Bellingham). 2018 Apr;5(2):021208
pubmed: 29376105
Cancers (Basel). 2020 May 11;12(5):
pubmed: 32403240
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Med Phys. 2019 Apr;46(4):1707-1718
pubmed: 30702759
AJR Am J Roentgenol. 2017 Sep;209(3):W145-W151
pubmed: 28657843
Int J Comput Assist Radiol Surg. 2018 Aug;13(8):1211-1219
pubmed: 29766373
Eur Urol Focus. 2021 Jan;7(1):78-85
pubmed: 31028016
Curr Probl Diagn Radiol. 2018 Nov;47(6):404-409
pubmed: 29126575
J Med Imaging (Bellingham). 2017 Oct;4(4):041307
pubmed: 29057288